The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Karnofsky Performance Status

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Karnofsky Performance Status


High impact information on Karnofsky Performance Status


Chemical compound and disease context of Karnofsky Performance Status


Biological context of Karnofsky Performance Status


Anatomical context of Karnofsky Performance Status


Associations of Karnofsky Performance Status with chemical compounds


Gene context of Karnofsky Performance Status


Analytical, diagnostic and therapeutic context of Karnofsky Performance Status


  1. Randomized phase II study of two gemcitabine schedules for patients with impaired performance status (Karnofsky performance status </= 70) and advanced non-small-cell lung cancer. Baka, S., Ashcroft, L., Anderson, H., Lind, M., Burt, P., Stout, R., Dowd, I., Smith, D., Lorigan, P., Thatcher, N. J. Clin. Oncol. (2005) [Pubmed]
  2. A phase I-II trial of induction chemotherapy with carboplatin and fluorouracil in locally advanced head and neck squamous cell carcinoma: a report from the UCL-Oncology Group, Belgium. Grégoire, V., Beauduin, M., Humblet, Y., Hamoir, M., Longueville, J., Majois, F., Remacle, F.M., Rousseau, F., Salamon, E., Wambersie, A. J. Clin. Oncol. (1991) [Pubmed]
  3. Poor prognosis associated with elevated serum CA 19-9 level in advanced colorectal carcinoma, independent of DNA ploidy or SPF. Kouri, M., Nordling, S., Kuusela, P., Pyrhönen, S. Eur. J. Cancer (1993) [Pubmed]
  4. Survival results from a phase I study of etanidazole (SR2508) and radiotherapy in patients with malignant glioma. Chang, E.L., Loeffler, J.S., Riese, N.E., Wen, P.Y., Alexander, E., Black, P.M., Coleman, C.N. Int. J. Radiat. Oncol. Biol. Phys. (1998) [Pubmed]
  5. Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse. Brada, M., Hoang-Xuan, K., Rampling, R., Dietrich, P.Y., Dirix, L.Y., Macdonald, D., Heimans, J.J., Zonnenberg, B.A., Bravo-Marques, J.M., Henriksson, R., Stupp, R., Yue, N., Bruner, J., Dugan, M., Rao, S., Zaknoen, S. Ann. Oncol. (2001) [Pubmed]
  6. Scleromyxedema: role of high-dose melphalan with autologous stem cell transplantation. Donato, M.L., Feasel, A.M., Weber, D.M., Prieto, V.G., Giralt, S.A., Champlin, R.E., Duvic, M. Blood (2006) [Pubmed]
  7. Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration. Smaletz, O., Scher, H.I., Small, E.J., Verbel, D.A., McMillan, A., Regan, K., Kelly, W.K., Kattan, M.W. J. Clin. Oncol. (2002) [Pubmed]
  8. Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma. Motzer, R.J., Bacik, J., Murphy, B.A., Russo, P., Mazumdar, M. J. Clin. Oncol. (2002) [Pubmed]
  9. Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: A retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy. Prados, M.D., Scott, C., Curran, W.J., Nelson, D.F., Leibel, S., Kramer, S. J. Clin. Oncol. (1999) [Pubmed]
  10. Phase II study of vinorelbine and low-dose docetaxel in chemotherapy-naive patients with hormone-refractory prostate cancer. Koletsky, A.J., Guerra, M.L., Kronish, L. Cancer journal (Sudbury, Mass.) (2003) [Pubmed]
  11. Posterior fossa metastases: risk of leptomeningeal disease when treated with stereotactic radiosurgery compared to surgery. Siomin, V.E., Vogelbaum, M.A., Kanner, A.A., Lee, S.Y., Suh, J.H., Barnett, G.H. J. Neurooncol. (2004) [Pubmed]
  12. Patient statement of satisfaction with antiemetic treatment is related to quality of life. Bosnjak, S., Radulović, S., Nesković-Konstantinović, Z., Mitrović, L. Am. J. Clin. Oncol. (2000) [Pubmed]
  13. Chemotherapy with cisplatin and vinorelbine for elderly patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC). Pereira, J.R., Martins, S.J., Nikaedo, S.M., Ikari, F.K. BMC Cancer (2004) [Pubmed]
  14. Phase II study of pemetrexed in patients pretreated with an anthracycline, a taxane, and capecitabine for advanced breast cancer. O'Shaughnessy, J.A., Clark, R.S., Blum, J.L., Mennel, R.G., Snyder, D., Ye, Z., Liepa, A.M., Melemed, A.S., Yardley, D.A. Clin. Breast Cancer (2005) [Pubmed]
  15. Longitudinal study on the Quality of Life of symptomatic HIV-infected patients in a trial of zidovudine versus zidovudine and interferon-alpha. de Boer, J.B., van Dam, F.S., Sprangers, M.A., Frissen, P.H., Lange, J.M. AIDS (1993) [Pubmed]
  16. Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced biliary carcinoma. Mani, S., Sciortino, D., Samuels, B., Arrietta, R., Schilsky, R.L., Vokes, E.E., Benner, S. Investigational new drugs. (1999) [Pubmed]
  17. Improved long term survival after intracavitary interleukin-2 and lymphokine-activated killer cells for adults with recurrent malignant glioma. Hayes, R.L., Koslow, M., Hiesiger, E.M., Hymes, K.B., Hochster, H.S., Moore, E.J., Pierz, D.M., Chen, D.K., Budzilovich, G.N., Ransohoff, J. Cancer (1995) [Pubmed]
  18. Results of three-dimensional conformal radiotherapy and thalidomide for advanced hepatocellular carcinoma. Hsu, W.C., Chan, S.C., Ting, L.L., Chung, N.N., Wang, P.M., Ying, K.S., Shin, J.S., Chao, C.J., Lin, G.D. Jpn. J. Clin. Oncol. (2006) [Pubmed]
  19. A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer. Slevin, M.L., Clark, P.I., Joel, S.P., Malik, S., Osborne, R.J., Gregory, W.M., Lowe, D.G., Reznek, R.H., Wrigley, P.F. J. Clin. Oncol. (1989) [Pubmed]
  20. Prospective validation of a pharmacologically based dosing scheme for the cis-diamminedichloroplatinum(II) analogue diamminecyclobutanedicarboxylatoplatinum. Egorin, M.J., Van Echo, D.A., Olman, E.A., Whitacre, M.Y., Forrest, A., Aisner, J. Cancer Res. (1985) [Pubmed]
  21. Prospective evaluation of hydrocortisone and suramin in patients with androgen-independent prostate cancer. Kelly, W.K., Curley, T., Leibretz, C., Dnistrian, A., Schwartz, M., Scher, H.I. J. Clin. Oncol. (1995) [Pubmed]
  22. Effects of thalidomide on HIV-associated wasting syndrome: a randomized, double-blind, placebo-controlled clinical trial. Reyes-Terán, G., Sierra-Madero, J.G., Martínez del Cerro, V., Arroyo-Figueroa, H., Pasquetti, A., Calva, J.J., Ruiz-Palacios, G.M. AIDS (1996) [Pubmed]
  23. Increasing the hematocrit has a beneficial effect on quality of life and is safe in selected hemodialysis patients. Spanish Cooperative Renal Patients Quality of Life Study Group of the Spanish Society of Nephrology. Moreno, F., Sanz-Guajardo, D., López-Gómez, J.M., Jofre, R., Valderrábano, F. J. Am. Soc. Nephrol. (2000) [Pubmed]
  24. Pretreatment vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC). Laack, E., Scheffler, A., Burkholder, I., Boeters, I., Andritzky, B., Schuch, G., Görn, M., Vohwinkel, G., Edler, L., Fiedler, W., Hossfeld, D.K. Lung Cancer (2005) [Pubmed]
  25. The relationship of epidermal growth factor receptor levels to the prognosis of unresectable pharyngeal cancer patients treated by chemo-radiotherapy. Magné, N., Pivot, X., Bensadoun, R.J., Guardiola, E., Poissonnet, G., Dassonville, O., Francoual, M., Formento, J.L., Demard, F., Schneider, M., Milano, G. Eur. J. Cancer (2001) [Pubmed]
  26. PAI-1 and EGFR expression in adult glioma tumors: toward a molecular prognostic classification. Muracciole, X., Romain, S., Dufour, H., Palmari, J., Chinot, O., Ouafik, L., Grisoli, F., Branger, D.F., Martin, P.M. Int. J. Radiat. Oncol. Biol. Phys. (2002) [Pubmed]
  27. Treatment of cachexia with ghrelin in patients with COPD. Nagaya, N., Itoh, T., Murakami, S., Oya, H., Uematsu, M., Miyatake, K., Kangawa, K. Chest (2005) [Pubmed]
  28. Long term follow-up of patients with recurrent ovarian cancer after Ad p53 gene replacement with SCH 58500. Buller, R.E., Shahin, M.S., Horowitz, J.A., Runnebaum, I.B., Mahavni, V., Petrauskas, S., Kreienberg, R., Karlan, B., Slamon, D., Pegram, M. Cancer Gene Ther. (2002) [Pubmed]
  29. Carcinoma of the oropharynx: local failure as the decisive parameter for distant metastases and survival. Beer, K.T., Greiner, R.H., Aebersold, D.M., Zbären, P. Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]. (2000) [Pubmed]
  30. Controlled study on the improvement of quality of life in elderly hemodialysis patients after correcting end-stage renal disease-related anemia with erythropoietin. Moreno, F., Aracil, F.J., Pérez, R., Valderrábano, F. Am. J. Kidney Dis. (1996) [Pubmed]
  31. A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme. Bauman, G.S., Gaspar, L.E., Fisher, B.J., Halperin, E.C., Macdonald, D.R., Cairncross, J.G. Int. J. Radiat. Oncol. Biol. Phys. (1994) [Pubmed]
  32. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Mehta, M.P., Tsao, M.N., Whelan, T.J., Morris, D.E., Hayman, J.A., Flickinger, J.C., Mills, M., Rogers, C.L., Souhami, L. Int. J. Radiat. Oncol. Biol. Phys. (2005) [Pubmed]
  33. Pervasive failed rehabilitation in center-based maintenance hemodialysis patients. Ifudu, O., Paul, H., Mayers, J.D., Cohen, L.S., Brezsnyak, W.F., Herman, A.I., Avram, M.M., Friedman, E.A. Am. J. Kidney Dis. (1994) [Pubmed]
WikiGenes - Universities